These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8556526)

  • 1. Role of cytoskeletal elements in expression of monocyte urokinase plasminogen activator receptor, activation-associated antigen Mo3.
    Washington R; Dore-Duffy P
    Clin Diagn Lab Immunol; 1994 Nov; 1(6):714-21. PubMed ID: 8556526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of monocyte activation antigen Mo3 on the surface of peripheral blood monocytes from patients with multiple sclerosis.
    Dore-Duffy P; Donovan C; Todd RF
    Neurology; 1992 Aug; 42(8):1609-14. PubMed ID: 1322513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator.
    Min HY; Semnani R; Mizukami IF; Watt K; Todd RF; Liu DY
    J Immunol; 1992 Jun; 148(11):3636-42. PubMed ID: 1316922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of cytoskeletal structures results in the induction of the urokinase-type plasminogen activator gene expression.
    Botteri FM; Ballmer-Hofer K; Rajput B; Nagamine Y
    J Biol Chem; 1990 Aug; 265(22):13327-34. PubMed ID: 1695907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT).
    Reinartz J; Link J; Todd RF; Kramer MD
    Exp Cell Res; 1994 Oct; 214(2):486-98. PubMed ID: 7925643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor.
    Conese M; Nykjaer A; Petersen CM; Cremona O; Pardi R; Andreasen PA; Gliemann J; Christensen EI; Blasi F
    J Cell Biol; 1995 Dec; 131(6 Pt 1):1609-22. PubMed ID: 8522616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system.
    Schaefer BM; Stark HJ; Fusenig NE; Todd RF; Kramer MD
    Exp Cell Res; 1995 Oct; 220(2):415-23. PubMed ID: 7556451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes.
    Bohuslav J; Horejsí V; Hansmann C; Stöckl J; Weidle UH; Majdic O; Bartke I; Knapp W; Stockinger H
    J Exp Med; 1995 Apr; 181(4):1381-90. PubMed ID: 7535337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ; Lee SW; Dichek DA; Ellis V
    J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urokinase anchors uPAR to the actin cytoskeleton.
    Bernstein AM; Greenberg RS; Taliana L; Masur SK
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2967-77. PubMed ID: 15326109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activation in bullous pemphigoid immunohistology reveals urokinase type plasminogen activator, its receptor and plasminogen activator inhibitor type-2 in lesional epidermis.
    Schaefer BM; Jaeger C; Drepper E; Kramer MD
    Autoimmunity; 1996; 23(3):155-64. PubMed ID: 8879451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase-type plasminogen activator (uPA) promotes ezrin-mediated reorganization of the synaptic cytoskeleton in the ischemic brain.
    Merino P; Diaz A; Manrique LG; Cheng L; Yepes M
    J Biol Chem; 2018 Jun; 293(24):9234-9247. PubMed ID: 29720403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells.
    Wickström SA; Veikkola T; Rehn M; Pihlajaniemi T; Alitalo K; Keski-Oja J
    Cancer Res; 2001 Sep; 61(17):6511-6. PubMed ID: 11522648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes.
    Chavakis T; Kanse SM; Yutzy B; Lijnen HR; Preissner KT
    Blood; 1998 Apr; 91(7):2305-12. PubMed ID: 9516128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes.
    Estreicher A; Mühlhauser J; Carpentier JL; Orci L; Vassalli JD
    J Cell Biol; 1990 Aug; 111(2):783-92. PubMed ID: 2166055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C mediates up-regulation of urokinase and its receptor in the migrating keratinocytes of wounded cultures, but urokinase is not required for movement across a substratum in vitro.
    Ando Y; Jensen PJ
    J Cell Physiol; 1996 Jun; 167(3):500-11. PubMed ID: 8655604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase expression in mononuclear phagocytes: cytokine-specific modulation by interferon-gamma and tumor necrosis factor-alpha.
    Gyetko MR; Shollenberger SB; Sitrin RG
    J Leukoc Biol; 1992 Mar; 51(3):256-63. PubMed ID: 1311745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase-type plasminogen activator stimulation of monocyte matrix metalloproteinase-1 production is mediated by plasmin-dependent signaling through annexin A2 and inhibited by inactive plasmin.
    Zhang Y; Zhou ZH; Bugge TH; Wahl LM
    J Immunol; 2007 Sep; 179(5):3297-304. PubMed ID: 17709546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells.
    Alfano M; Mariani SA; Elia C; Pardi R; Blasi F; Poli G
    Blood; 2009 Feb; 113(8):1699-709. PubMed ID: 18941116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
    Plesner T; Behrendt N; Ploug M
    Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.